| # | Title | Journal | Year | Citations |
|---|
| 1 | 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus | Annals of the Rheumatic Diseases | 2019 | 759 |
| 2 | Gene Copy-Number Variation and Associated Polymorphisms of Complement Component C4 in Human Systemic Lupus Erythematosus (SLE): Low Copy Number Is a Risk Factor for and High Copy Number Is a Protective Factor against SLE Susceptibility in European Americans | American Journal of Human Genetics | 2007 | 411 |
| 3 | Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial | Lancet, The | 2018 | 396 |
| 4 | HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis | Lancet, The | 1993 | 359 |
| 5 | Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) | Journal of Rheumatology | 2003 | 356 |
| 6 | The role of miRNA in inflammation and autoimmunity | Autoimmunity Reviews | 2013 | 275 |
| 7 | High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis | Annals of the Rheumatic Diseases | 2011 | 269 |
| 8 | Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus | Nature Genetics | 2011 | 242 |
| 9 | A Functional Variant in MicroRNA-146a Promoter Modulates Its Expression and Confers Disease Risk for Systemic Lupus Erythematosus | PLoS Genetics | 2011 | 241 |
| 10 | The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: Roles of inflammation and dyslipidemia | Journal of Autoimmunity | 2007 | 210 |
| 11 | Hydroxychloroquine directly reduces the binding of antiphospholipid antibody–β2-glycoprotein I complexes to phospholipid bilayers | Blood | 2008 | 208 |
| 12 | Th17 cells in inflammation and autoimmunity | Autoimmunity Reviews | 2014 | 182 |
| 13 | Association of Genetic Variants in Complement Factor H and Factor H-Related Genes with Systemic Lupus Erythematosus Susceptibility | PLoS Genetics | 2011 | 181 |
| 14 | Pathogenesis of ankylosing spondylitis | Nature Reviews Rheumatology | 2010 | 169 |
| 15 | Rituximab Treatment of Patients with Severe, Corticosteroid-Resistant Thyroid-Associated Ophthalmopathy | Ophthalmology | 2010 | 159 |
| 16 | Human Monoclonal Antiphospholipid Antibodies Disrupt the Annexin A5 Anticoagulant Crystal Shield on Phospholipid Bilayers | American Journal of Pathology | 2003 | 154 |
| 17 | A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases | Nature Genetics | 2017 | 143 |
| 18 | Dicer Insufficiency and MicroRNA-155 Overexpression in Lupus Regulatory T Cells: An Apparent Paradox in the Setting of an Inflammatory Milieu | Journal of Immunology | 2011 | 121 |
| 19 | GWAS identifies novel SLE susceptibility genes and explains the association of the HLA region | Genes and Immunity | 2014 | 109 |
| 20 | Admixture Mapping in Lupus Identifies Multiple Functional Variants within IFIH1 Associated with Apoptosis, Inflammation, and Autoantibody Production | PLoS Genetics | 2013 | 107 |
| 21 | MicroRNA-3148 Modulates Allelic Expression of Toll-Like Receptor 7 Variant Associated with Systemic Lupus Erythematosus | PLoS Genetics | 2013 | 107 |
| 22 | CD8+ T Cell-Mediated Suppression of Autoimmunity in a Murine Lupus Model of Peptide-Induced Immune Tolerance Depends on Foxp3 Expression | Journal of Immunology | 2007 | 100 |
| 23 | Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis | Arthritis Research and Therapy | 2008 | 94 |
| 24 | Identification of a Systemic Lupus Erythematosus Risk Locus Spanning ATG16L2, FCHSD2, and P2RY2 in Koreans | Arthritis and Rheumatology | 2016 | 89 |
| 25 | Measurement of structural progression in osteoarthritis of the hip: the Barcelona consensus group11Supported by an unrestricted grant from NEGMA-LERADS Laboratories. | Osteoarthritis and Cartilage | 2004 | 88 |
| 26 | Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention | Expert Review of Clinical Immunology | 2011 | 88 |
| 27 | T-regulatory cells in systemic lupus erythematosus | Lupus | 2008 | 87 |
| 28 | The Minimally Important Difference for the Fatigue Visual Analog Scale in Patients with Rheumatoid Arthritis Followed in an Academic Clinical Practice | Journal of Rheumatology | 2008 | 85 |
| 29 | Cytokines in Systemic Lupus Erythematosus | Current Molecular Medicine | 2009 | 85 |
| 30 | Atherosclerosis and systemic lupus erythematosus — mechanistic basis of the association | Current Opinion in Immunology | 2007 | 82 |
| 31 | Periostitis and Hypertrophic Pulmonary Osteoarthropathy: Report of 2 Cases and Review of the Literature | Seminars in Arthritis and Rheumatism | 2009 | 80 |
| 32 | Characterization of IgG monoclonal anti-cardiolipin/anti-beta2GP1 antibodies from two patients with antiphospholipid syndrome reveals three species of antibodies | British Journal of Haematology | 1999 | 79 |
| 33 | PD-1, gender, and autoimmunity | Autoimmunity Reviews | 2010 | 79 |
| 34 | Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity | Arthritis Research and Therapy | 2011 | 75 |
| 35 | Development of a provisional core set of response measures for clinical trials of systemic sclerosis | Annals of the Rheumatic Diseases | 2007 | 74 |
| 36 | A peptide derived from an autoantibody can stimulate t cells in the (nzb × nzw)f1 mouse model of systemic lupus erythematosus | Arthritis and Rheumatism | 1993 | 70 |
| 37 | ABIN1 Dysfunction as a Genetic Basis for Lupus Nephritis | Journal of the American Society of Nephrology: JASN | 2013 | 70 |
| 38 | Cutting Edge: Fasting-Induced Hypoleptinemia Expands Functional Regulatory T Cells in Systemic Lupus Erythematosus | Journal of Immunology | 2012 | 69 |
| 39 | pConsensus Peptide Induces Tolerogenic CD8+ T Cells in Lupus-Prone (NZB × NZW)F1 Mice by Differentially Regulating Foxp3 and PD1 Molecules | Journal of Immunology | 2008 | 65 |
| 40 | Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus | Proceedings of the National Academy of Sciences of the United States of America | 2007 | 62 |
| 41 | Defining Skin Ulcers in Systemic Sclerosis: Systematic Literature Review and Proposed World Scleroderma Foundation (WSF) Definition | Journal of Scleroderma and Related Disorders | 2017 | 62 |
| 42 | Current topics in human SLE genetics | Seminars in Immunopathology | 2006 | 61 |
| 43 | Anti‐DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients | Arthritis and Rheumatism | 2008 | 60 |
| 44 | Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trial | Annals of the Rheumatic Diseases | 2011 | 60 |
| 45 | Antinuclear antibody-negative systemic sclerosis | Seminars in Arthritis and Rheumatism | 2015 | 60 |
| 46 | Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis | Genes and Immunity | 2012 | 58 |
| 47 | A human monoclonal antiprothrombin antibody is thrombogenic in vivo and upregulates expression of tissue factor and E-selectin on endothelial cells | British Journal of Haematology | 2006 | 57 |
| 48 | Saliva exosomes from pancreatic tumor–bearing mice modulate NK cell phenotype and antitumor cytotoxicity | FASEB Journal | 2017 | 57 |
| 49 | PTPN22 Association in Systemic Lupus Erythematosus (SLE) with Respect to Individual Ancestry and Clinical Sub-Phenotypes | PLoS ONE | 2013 | 57 |
| 50 | Role of bacteria and HLA-B27 in the pathogenesis of reactive arthritis | Rheumatic Disease Clinics of North America | 2003 | 55 |
